FG Issues Public Alert on Life-Destroying Medication with Fake NAFDAC Number
- NAFDAC has raised an urgent alert over the circulation of a falsified Oxytocin injection branded as Gold Vision Oxytocin Injection 10IU
- The agency said the product, bearing a fake registration number and linked to a Chinese manufacturer, posed serious health risks to mothers and newborns
- Investigations have uncovered multiple unregistered injections with identical fraudulent credentials, prompting calls for public vigilance and immediate reporting
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public warning regarding the circulation of an unregistered and potentially dangerous Oxytocin injection marketed under the name Gold Vision Oxytocin Injection 10IU.
The product reportedly carries a falsified NAFDAC Registration Number: A4-9566.
Source: Twitter
According to NAFDAC, the product was discovered during a risk-based sampling survey conducted by its officers.
The injection is purportedly manufactured by Anhui Hongye Pharmaceutical Co., Ltd., located at Fengyang East Road, Bengbu, Anhui Province, China, and marketed by Gold Vision Medicals, based at No.4 Range Avenue, Independence Layout, Enugu, Nigeria.
Further investigation showed that three additional falsified products—A-tocin Injection, Extocin Injection, and Claxitodin Injection—were also identified during the 2023 Risk-Based Product Monitoring Survey (RBPMS).
All four products reportedly bear the same fake NAFDAC registration number and are believed to be manufactured by the same company.
NAFDAC confirms products are not registered
NAFDAC confirmed that none of the identified products are listed in its official database of registered medicines, thereby classifying them as falsified. The agency emphasised that the presence of these unregistered injections in the market poses a significant threat to public health.
Health risks of unregistered Oxytocin injections
Medical experts warn that the use of unregistered or falsified Oxytocin injections can result in severe health complications for both mothers and newborns. These products may contain incorrect dosages, lack active ingredients, or include harmful contaminants. Such deficiencies could lead to ineffective uterine contractions, postpartum haemorrhage (PPH), and, in extreme cases, maternal death.
NAFDAC further noted that poor-quality Oxytocin may fail to control bleeding after childbirth, potentially necessitating emergency interventions such as blood transfusions or surgical procedures.
See the X post below:
NAFDAC asks Nigerians to report suspicious products
In light of the findings, NAFDAC has urged healthcare professionals and consumers to remain vigilant and report any suspicion of substandard or falsified medical products.
The agency said reports can be made to the nearest NAFDAC office, via the toll-free number 0800-162-3322, or by email at sf.alert@nafdac.gov.ng.
The agency reiterated its commitment to safeguarding public health and ensuring that only safe, effective, and properly registered medical products are available in Nigeria.
Source: Twitter
NAFDAC issues alert on fake postinor
Legit.ng earlier reported that NAFDAC issued a public alert regarding the circulation of falsified Type 1 and Type 2 batches of Postinor-2 (Levonorgestrel 0.75mg), a widely used emergency contraceptive pill.
The agency confirmed that the counterfeit products pose serious risks to public health and safety. According to NAFDAC, the alert followed a report from the Society of Family Health (SFH), the Marketing Authorisation Holder (MAH), which stated that the company had not imported the affected product batches.
Proofreading by James Ojo, copy editor at Legit.ng.
Source: Legit.ng
